Delirium at the End of Life

被引:17
作者
Agar, Meera [1 ]
Bush, Shirley H. [2 ,3 ,4 ,5 ]
机构
[1] Univ Technol Sydney, Fac Hlth, IMPACCT Improving Palliat Aged & Chron Care Clin, Bldg 10,Level 3,235 Jones St, Ultimo, NSW 2007, Australia
[2] Ottawa Hosp, Gen Campus,501 Smyth Rd,Box 206, Ottawa, ON K1H 8L6, Canada
[3] Bruyere Res Inst, 85 Primrose Ave, Ottawa, ON K1R 6M1, Canada
[4] Ottawa Hosp, Res Inst, 053 Carling Ave, Ottawa, ON K1Y 4E9, Canada
[5] Ottawa Hosp, Bruyere Continuing Care, Palliat Care, 43 Bruyere St, Ottawa, ON K1N 5C8, Canada
关键词
Delirium; Delirium pathophysiology; Delirium screening; Delirium prevention; Antipsychotics; Benzodiazepines; Palliative care; End of life; PALLIATIVE CARE; SUBSYNDROMAL DELIRIUM; ADVANCED CANCER; TERMINALLY-ILL; DEMENTIA; PLACEBO; HALOPERIDOL; VALIDATION; PREDICTORS; EFFICACY;
D O I
10.1016/j.mcna.2020.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Delirium is a prevalent acute neurocognitive condition in patients with progressive life-limiting illness. Delirium remains underdetected; a systematic approach to screening is essential. Delirium at the end of life requires a comprehensive assessment. Consider the potential for reversibility, illness trajectory, patient preference, and goals of care before proceeding with investigations and interventions. Management should be interdisciplinary, and nonpharmacologic therapy is fundamental. For patients with refractory and severe agitation or perceptual disturbance, judicious use of medication may also be required. Carers and family should be seen as partners in care and be involved in shared decision making about care.
引用
收藏
页码:491 / +
页数:12
相关论文
共 40 条
[1]   Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care A Randomized Clinical Trial [J].
Agar, Meera R. ;
Lawlor, Peter G. ;
Quinn, Stephen ;
Draper, Brian ;
Caplan, Gideon A. ;
Rowett, Debra ;
Sanderson, Christine ;
Hardy, Janet ;
Le, Brian ;
Eckermann, Simon ;
McCaffrey, Nicola ;
Devilee, Linda ;
Fazekas, Belinda ;
Hill, Mark ;
Currow, David C. .
JAMA INTERNAL MEDICINE, 2017, 177 (01) :34-42
[2]   Predictors of Mortality for Delirium in Palliative Care [J].
Agar, Meera R. ;
Quinn, Stephen J. ;
Crawford, Gregory B. ;
Ritchie, Christine S. ;
Phillips, Jane L. ;
Collier, Aileen ;
Currow, David C. .
JOURNAL OF PALLIATIVE MEDICINE, 2016, 19 (11) :1205-1209
[3]  
American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, P596, DOI DOI 10.1176/APPI.BOOKS.9780890425596
[4]  
Baird L., 2017, BMJ Open Qual, V6, pe000153, DOI [DOI 10.1136/BMJOQ-2017-000153, 10.1136/bmjoq-2017-000153]
[5]   Rating Delirium Severity Using the Nursing Delirium Screening Scale: A Validation Study in Patients in Palliative Care [J].
Barnes, Christopher J. ;
Webber, Colleen ;
Bush, Shirley H. ;
McNamara-Kilian, Marie ;
Brodeur, Jennifer ;
Marchington, Katie ;
Sabri, Elham ;
Lawlor, Peter G. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 58 (04) :E4-E7
[6]   Treatment characteristics of delirium superimposed on dementia [J].
Boettger, Soenke ;
Passik, Steven ;
Breitbart, William .
INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (10) :1671-1676
[7]   The Memorial Delirium Assessment Scale [J].
Breitbart, W ;
Rosenfeld, B ;
Roth, A ;
Smith, MJ ;
Cohen, K ;
Passik, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (03) :128-137
[8]   Evidence-Based Treatment of Delirium in Patients With Cancer [J].
Breitbart, William ;
Alici, Yesne .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (11) :1206-1214
[9]  
Breitbart W, 2008, JAMA-J AM MED ASSOC, V300, P2898, DOI 10.1001/jama.2008.885
[10]   Antipsychotics for treatment of deliriumin hospitalised non-ICU patients [J].
Burry, Lisa ;
Mehta, Sangeeta ;
Perreault, Marc M. ;
Luxenberg, Jay S. ;
Siddiqi, Najma ;
Hutton, Brian ;
Fergusson, Dean A. ;
Bell, Chaim ;
Rose, Louise .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (06)